192 related articles for article (PubMed ID: 3254259)
1. Differentiation of autoimmune ophthalmopathy from Graves' hyperthyroidism by analysis of genetic markers.
Kendall-Taylor P; Stephenson A; Stratton A; Papiha SS; Perros P; Roberts DF
Clin Endocrinol (Oxf); 1988 Jun; 28(6):601-10. PubMed ID: 3254259
[TBL] [Abstract][Full Text] [Related]
2. Genetic factors in Graves' ophthalmopathy.
Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
[TBL] [Abstract][Full Text] [Related]
4. Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: genetic characteristics of euthyroid Graves' ophthalmopathy.
Inoue D; Sato K; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
Clin Endocrinol (Oxf); 1991 Jan; 34(1):57-62. PubMed ID: 2004473
[TBL] [Abstract][Full Text] [Related]
5. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR associations with Graves' disease in eastern Hungary.
Stenszky V; Kozma L; Balazs C; Farid NR
Clin Invest Med; 1983; 6(3):181-4. PubMed ID: 6580983
[TBL] [Abstract][Full Text] [Related]
7. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
[TBL] [Abstract][Full Text] [Related]
8. Immunogenetics of Graves' ophthalmopathy.
Weetman AP; So AK; Warner CA; Foroni L; Fells P; Shine B
Clin Endocrinol (Oxf); 1988 Jun; 28(6):619-28. PubMed ID: 2908181
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
10. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
11. HLA and autoimmune endocrine disease 1985.
Farid NR; Thompson C
Mol Biol Med; 1986 Feb; 3(1):85-97. PubMed ID: 3485759
[TBL] [Abstract][Full Text] [Related]
12. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
[TBL] [Abstract][Full Text] [Related]
13. The pathogenesis of Graves' ophthalmopathy.
Kendall-Taylor P
Clin Endocrinol Metab; 1985 May; 14(2):331-49. PubMed ID: 2415275
[TBL] [Abstract][Full Text] [Related]
14. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations.
Inoue D; Sato K; Enomoto T; Sugawa H; Maeda M; Inoko H; Tsuji K; Mori T; Imura H
Clin Endocrinol (Oxf); 1992 Jan; 36(1):75-82. PubMed ID: 1559302
[TBL] [Abstract][Full Text] [Related]
15. Human lymphocyte antigens in Graves' disease: correlation with persistent course of disease.
Baldini M; Pappalettera M; Lecchi L; Orsatti A; Meroni L; Tozzi R; Scalamogna M; Cantalamessa L
Am J Med Sci; 1995 Jan; 309(1):43-8. PubMed ID: 7825652
[TBL] [Abstract][Full Text] [Related]
16. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease.
Farid NR; Barnard JM; Marshall WH
Tissue Antigens; 1976 Sep; 8(3):181-9. PubMed ID: 989647
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR4 associated response to corticosteroids in Graves' ophthalmopathy patients.
van der Gaag R; Wiersinga WM; Koornneef L; Mourits MP; Prummel MF; Berghout A; de Vries RR; Schreuder GM; D'Amaro J
J Endocrinol Invest; 1990 Jun; 13(6):489-92. PubMed ID: 2258577
[TBL] [Abstract][Full Text] [Related]
18. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
19. Genetic markers in diagnosis and prediction of relapse in Graves' disease.
Badenhoop K; Donner H; Braun J; Siegmund T; Rau H; Usadel KH
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():98-100. PubMed ID: 8981012
[TBL] [Abstract][Full Text] [Related]
20. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]